{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:38:43Z","timestamp":1783042723569,"version":"3.54.6"},"reference-count":84,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1996,12]]},"abstract":"<jats:p>\n            Aldosterone, the most important mineralocorticoid, regulates electrolyte excretion and intravascular volume mainly through its effects on renal distal convoluted tubules and cortical collecting ducts. Excess secretion of aldosterone or other mineralocorticoids or abnormal sensitivity to mineralocorticoids may result in hypertension, suppressed plasma renin activity, and hypokalemia. Such conditions often have a genetic basis, and studies of these conditions have provided valuable insights into the normal and abnormal physiology of mineralocorticoid action. Deficiencies of steroid 11\u03b2-hydroxylase or 17\u03b1-hydroxylase are types of congenital adrenal hyperplasia, the autosomal recessive inability to synthesize cortisol. These two defects often cause hypertension because of overproduction of cortisol precursors that are, or are metabolized to, mineralocorticoid agonists. These disorders result from mutations in the\n            <jats:italic>CYP11B1<\/jats:italic>\n            and\n            <jats:italic>CYP17<\/jats:italic>\n            genes encoding the corresponding enzymes. Glucocorticoid-suppressible hyperaldosteronism is an autosomal dominant form of hypertension in which aldosterone secretion is abnormally regulated by corticotropin. It is caused by recombinations between linked genes encoding closely related isozymes, 11\u03b2-hydroxylase (\n            <jats:italic>CYP11B1<\/jats:italic>\n            ) and aldosterone synthase (\n            <jats:italic>CYP11B2<\/jats:italic>\n            ), generating a dysregulated chimeric gene with aldosterone synthase activity. Apparent mineralocorticoid excess is a loss of functional ligand specificity of the mineralocorticoid receptor caused by a deficiency of the kidney isozyme of 11\u03b2-hydroxysteroid dehydrogenase, an enzyme that normally metabolizes cortisol to cortisone to prevent cortisol from occupying the receptor. This autosomal recessive form of severe hypertension results from mutations in the\n            <jats:italic>HSD11K<\/jats:italic>\n            (\n            <jats:italic>HSD11B2<\/jats:italic>\n            ) gene.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.28.6.927","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:53:46Z","timestamp":1339462426000},"page":"927-936","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":58,"title":["Inherited Forms of Mineralocorticoid Hypertension"],"prefix":"10.1161","volume":"28","author":[{"given":"Perrin C.","family":"White","sequence":"first","affiliation":[{"name":"the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199407283310408"},{"key":"e_1_3_2_2_2","first-page":"421","volume":"15","year":"1994","unstructured":"White PC, Curnow KM, Pascoe L. Disorders of steroid 11 beta hydroxylase isozymes. Endocr Rev. 1994;15:421-438.","journal-title":"Endocr Rev"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7892608"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-12-1-91"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320420617"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-50-3-586"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-2-222"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-2-218"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(88)90171-9"},{"key":"e_1_3_2_10_2","first-page":"771","volume":"139","year":"1985","unstructured":"Hochberg Z, Schechter J, Benderly A, Leiberman E, Rosler A. Growth and pubertal development in patients with congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Am J Dis Child. 1985;139:771-776.","journal-title":"Am J Dis Child"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-5-896"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)30030-4"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.20.7193"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(91)90491-V"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.17.8327"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0992-66"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.11.4996"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-5-10-1513"},{"key":"e_1_3_2_19_2","first-page":"1278","volume":"75","year":"1992","unstructured":"Helmberg A, Ausserer B, Kofler R. Frame shift by insertion of 2 basepairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. J Clin Endocrinol Metab. 1992;75:1278-1281.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.10.4552"},{"key":"e_1_3_2_21_2","first-page":"1677","volume":"77","year":"1993","unstructured":"Naiki Y, Kawamoto T, Mitsuuchi Y, Miyahara K, Toda K, Orii T, Imura H, Shizuta Y. A nonsense mutation (TGG [Trp116]--TAG [Stop] in CYP11B1 causes steroid 11beta-hydroxylase deficiency. J Clin Endocrinol Metab. 1993;77:1677-1682.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_22_2","unstructured":"Geley S Kapelari K Johrer K Peter M Glatzl J Vierhapper H Sippell WG White PC Kofler R. CYP11B1 mutations causing congenital adrenal hyperplasia due to 11\u03b2-hydroxylase deficiency. J Clin Endocrinol Metab. In press."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115182"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)68746-0"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(91)06073-C"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8342039"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30101-4"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-2-6-564"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1987.6.439"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1991.10.359"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(95)00029-Y"},{"key":"e_1_3_2_32_2","first-page":"1109","volume":"95","year":"1966","unstructured":"Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J. 1966;95:1109-1119.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-27-2-300"},{"key":"e_1_3_2_34_2","unstructured":"New MI Borelli P eds. Dexamethasone-Suppressible Hyperaldosteronism. Rome Italy: Serono Symposia; 1986."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-1-22"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.8.4.317"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-10-813"},{"key":"e_1_3_2_38_2","first-page":"255","volume":"3","year":"1989","unstructured":"O'Mahony S, Burns A, Murnaghan DJ. Dexamethasone-suppressible hyperaldosteronism: a large new kindred. J Hum Hypertens. 1989;3:255-258.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-1-158"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.6.4.563"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30266-4"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1988.tb01080.x"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-5-1151"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93225-C"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118279"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(94)00010-A"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0880563"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/07435809509030459"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.3.7883820"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-5-757"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-56-2-332"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb00160.x"},{"key":"e_1_3_2_54_2","first-page":"821","volume":"2","year":"1987","unstructured":"Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2:821-824.","journal-title":"Lancet"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-2-1046"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3037703"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.19.6056"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90742-8"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2845584"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-123-5-2390"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)47248-7"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)55351-5"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-3-1700"},{"key":"e_1_3_2_64_2","first-page":"687","volume":"77","year":"1993","unstructured":"Nikkila H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC. Defects in the HSD11 gene encoding 11\u03b2-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Metab. 1993;77:687-691.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)82044-0"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.132.6.8504762"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(94)90016-7"},{"key":"e_1_3_2_68_2","first-page":"1529","volume":"78","year":"1994","unstructured":"Stewart PM, Murry BA, Mason JI. Type 2 11beta-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab. 1994;78:1529-1532.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)47142-6"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90030-2"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.1231"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0895-394"},{"key":"e_1_3_2_73_2","first-page":"2263","volume":"80","year":"1995","unstructured":"Wilson RC, Krozowski ZS, Li K, Obeyesekere VR, Razzaghy-Azar M, Harbison MD, Wei JQ, Shackleton CH, Funder JW, New MI. A mutation in the HSD11B2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 1995;80:2263-2266.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_74_2","first-page":"3145","volume":"80","year":"1995","unstructured":"Wilson RC, Harbison MD, Krozowski ZS, Funder JW, Shackleton CH, Hanauske-Abel HM, Wei JQ, Hertecant J, Moran A, Neiberger RE, Balfe JW, Fattah A, Daneman D, Licholai T, New MI. Several homozygous mutations in the gene for 11\u03b2-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 1995;80:3145-3150.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90211-1"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.27.6.1193"},{"key":"e_1_3_2_77_2","first-page":"3381","volume":"80","year":"1995","unstructured":"Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, Funder JW, Krozowski ZS. The R337C mutation generates a high Km 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 1995;80:3381-3383.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.705336"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90148-A"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90138-7"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6746.259"},{"key":"e_1_3_2_82_2","first-page":"885","volume":"80","year":"1995","unstructured":"Stewart PM, Rogerson FM, Mason JI. Type 2 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab. 1995;80:885-890.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.19.8545"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3612"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.28.6.927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T17:29:24Z","timestamp":1715534964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.28.6.927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["10.1161\/01.HYP.28.6.927"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.28.6.927","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"1996-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-07-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1996-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}